Drug · DIN 02451492
KOVALTRY
SINGLE-USE VIAL, 5 ML PREFILLED DILUENT SYRINGE WITH VIAL ADAPTER
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 18, 2016; first marketed August 18, 2016.
- Drug Identification Number (DIN)
- 02451492
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Schedule D
- Dosage form
- Kit; Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor viii B02BD02
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 3000 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 27, 2016: NOC 17727New Drug Submission (NDS)
Other DINs named KOVALTRY
- DIN 02451441 · Marketed
- DIN 02451468 · Marketed
- DIN 02451476 · Marketed
- DIN 02451484 · Marketed
- DIN 02451603 · Cancelled Pre Market
- DIN 02451611 · Cancelled Pre Market
- DIN 02451638 · Cancelled Pre Market
- DIN 02451646 · Cancelled Pre Market
- DIN 02451654 · Cancelled Pre Market